Classical and new prognostic factors in chronic lymphocytic leukemia: Where to now?

Hematology Journal

Volumn 3, Issue 1, 2002, Pages 7-9

  Montserrat, Emili ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Chronic lymphocytic leukemia; CLL; Prognosis; Prognostic factors

Indexed keywords

ALKYLATING AGENT; BIOCHEMICAL MARKER; BIOLOGICAL MARKER;

ARTICLE; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ISOLATION; GENE MUTATION; GENE SEQUENCE; HUMAN; LYMPHOCYTE COUNT; PROGNOSIS; REPRODUCIBILITY; STANDARDIZATION; SURVIVAL TIME; BLOOD; CHROMOSOME ANALYSIS; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; MORTALITY; REVIEW;

BIOLOGICAL MARKERS; CYTOGENETIC ANALYSIS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC; NEOPLASM STAGING; PROGNOSIS;

EID: 85047683837     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200139     Document Type: Article

References (10)

1. Clinical staging of chronic lymphocytic leukemia
2. A new prognostic classification of chronic lymphocytic leukemia derived from a multi-variate survival analysis
3. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: Clinical, therapeutic, and prognostic features
4. Chronic lymphocytic leukemia: Staging and prognostic factors
5. Statistical aspects of prognostic factor studies in oncology
6. Assessing the generalizability of prognostic information
7. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
8. Genomic aberrations and survival in chronic lymphocytic leukemia
9. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
10. H genes are associated with a more aggressive form of chronic lymphocytic leukemia